Eschrich, Steven

Radiomics: the process and the challenges

Kumar, V., Gu, Y., Basu, S., Berglund, A., Eschrich, S. A., Schabath, M. B., Forster, K., Aerts, H. J. W. L., Dekker, A., Fenstermacher, D., et al. (2012) · Magnetic Resonance Imaging

Radiomics and Machine Learning in Medical ImagingImage Retrieval and Classification Techniques

Cited by 2,258

Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells

Gritsko, T., Williams, A., Turkson, J., Kaneko, S., Bowman, T., Huang, M., Nam, S., Eweis, I., Diaz, N., Sullivan, D., et al. (2006) · Clinical Cancer Research

Cytokine Signaling Pathways and InteractionsCell death mechanisms and regulation

Cited by 563

A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study

Scott, J. G., Berglund, A., Schell, M. J., Mihaylov, I., Fulp, W. J., Yue, B., Welsh, E., Caudell, J. J., Ahmed, K., Strom, T. S., et al. (2017) · The Lancet Oncology

Breast Cancer Treatment StudiesAdvanced Radiotherapy Techniques

Cited by 474

12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy?

Messina, J. L., Fenstermacher, D. A., Eschrich, S., Qu, X., Berglund, A. E., Lloyd, M. C., Schell, M. J., Sondak, V. K., Weber, J. S., & Mulé, J. J. (2012) · Scientific Reports

Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management

Cited by 426

A Gene Expression Model of Intrinsic Tumor Radiosensitivity: Prediction of Response and Prognosis After Chemoradiation

Eschrich, S. A., Pramana, J., Zhang, H., Zhao, H., Boulware, D., Lee, J.-H., Bloom, G., Rocha-Lima, C., Kelley, S., Calvin, D. P., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics

Breast Cancer Treatment StudiesRadiation Therapy and Dosimetry

Cited by 360

Quantitative Computed Tomographic Descriptors Associate Tumor Shape Complexity and Intratumor Heterogeneity with Prognosis in Lung Adenocarcinoma

Grove, O., Berglund, A. E., Schabath, M. B., Aerts, H. J. W. L., Dekker, A., Wang, H., Velazquez, E. R., Lambin, P., Gu, Y., Balagurunathan, Y., et al. (2015) · PLOS ONE

Radiomics and Machine Learning in Medical ImagingAI in cancer detection

Cited by 263

Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis

Scott, J. G., Sedor, G., Ellsworth, P., Scarborough, J. A., Ahmed, K. A., Oliver, D. E., Eschrich, S. A., Kattan, M. W., & Torres-Roca, J. F. (2021) · The Lancet Oncology

Advanced Radiotherapy TechniquesRadiation Therapy and Dosimetry

Cited by 158

Necdin, a negative growth regulator, is a novel STAT3 target gene down-regulated in human cancer

Haviland, R., Eschrich, S., Bloom, G., Ma, Y., Minton, S., Jove, R., & Cress, W. D. (2011) · PLoS ONE

Cytokine Signaling Pathways and InteractionsProtein Tyrosine Phosphatases

Cited by 19

Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature

Scarborough, J. A., Eschrich, S. A., Torres-Roca, J., Dhawan, A., & Scott, J. G. (2023) · npj Precision Oncology

Gene expression and cancer classificationBreast Cancer Treatment Studies

Cited by 14